Prevalence and Clinical Impact of SARS‐CoV‐2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID‐19 Pandemic

INTRODUCTION: In Europe, the SARS‐CoV‐2 pandemic had its first epicenter in Italy. Despite a significant mortality rate, the severity of most cases of COVID‐19 infection ranges from asymptomatic to mildly symptomatic, and silent infection affects a still‐unknown proportion of the general population....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Zambelli, Alberto, Chiudinelli, Lorenzo, Fotia, Vittoria, Negrini, Giorgia, Bosetti, Tommaso, Callegaro, Annapaola, Di Croce, Andrea, Caremoli, Elena Rota, Moro, Cecilia, Milesi, Laura, Poletti, Paola, Tasca, Cristina, Mandalà, Mario, Merelli, Barbara, Mosconi, Stefania, Arnoldi, Ermenegildo, Bettini, Anna, Bonomi, Lucia, Messina, Caterina, Ghilardi, Laura, Chirco, Alessandra, Maracino, Michela, Tondini, Carlo
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2021
Matèries:
Symptom Management and Supportive Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018331/
https://ncbi.nlm.nih.gov/pubmed/33355953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13654
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars